Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit B4 pseudogene 11 (NDUFB4P11) is a pseudogene located on chromosome 14 (14q32.11). Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional; they do not code for a functional protein due to mutations or lack of necessary regulatory elements. While some pseudogenes are transcribed into RNA and may rarely have regulatory effects on their parental genes, there is currently no evidence that NDUFB4P11 has any characterized function or clinical significance. This gene is part of the broader family of pseudogenes related to components of mitochondrial complex I, but, unlike functional NDUFB4, NDUFB4P11 does not encode a mitochondrial protein or participate in cellular respiration. Pseudogenes, including NDUFB4P11, are not considered classical therapeutic targets. There is growing interest in their noncoding RNA roles, but NDUFB4P11 itself has no established function, disease association, or relevance as a target in drug discovery or clinical medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 11 (NDUFB4P11).